Loblo Logo Loblo
Invite-only
Pricing decision intelligence

Don’t guess your pricing.
Explore its consequences.

We help teams turn pricing decisions into an unfair advantage — by simulating real buyer sessions at scale and revealing opportunities, weaknesses, and unintended consequences in minutes, before the market does.

Revenue–margin tradeoffs
SKU cannibalization
Competitive leakage
Request Access →

A/B testing shows what happens.
Simulation shows why.

With in sales and pricing scenarios modelled, Loblo's simulations are rooted in transparent buyer journeys that are robust and reviewable.

Buyer session 65
Purchased competitor Sitvera Apex Ergonomic Chair (apex_pro)
Final confidence: 0.69
Considered SKUs
Northpeak Atlas Pro Ergonomic Chair, Northpeak Atlas Elite Ergonomic Chair
Initial price impression
mixed
Initial emotional reaction
Some of these are clearly out of my range, but the smaller panels dont feel crazy. I want something practical, not a huge commitment.
Initial decision
Purchased
Initial selected SKU
Northpeak Atlas Pro Ergonomic Chair (sku_atlas_pro)
Initial confidence
0.66
Primary reason
Better overall value than the smallest chair while staying under my spend line.
Secondary reasons
60-day trial lowers the risk if I dont end up using it; Simple proven wavelengths and timer-focused usability
Price perception summary
$369 feels like a safe buy; $449+ starts to feel like Im paying for more coverage than I know I need yet.
Post-decision rationalization
This should be enough to tell if ergonomic chair fits my routine without overspending. If it helps, I can upgrade later with more confidence.
Competitive research
Yes
Post-research reaction
Sitvera's Apex Ergonomic Chair at $359 jumps out because it's basically the same spend band I was targeting, but in a product that seems more clearly configurable than the entry-level options.
Decision changed
true
Final decision
Purchased competitor
Final selected SKU
Sitvera Apex Ergonomic Chair (apex_pro)
Final confidence
0.69
Confidence delta
0.03
Research impact summary
Competitor research slightly improved the perceived value at my budget by showing a half-body-leaning option under $400 with practical features. I liked Northpeak Atlas Pro Ergonomic Chair as a safe mid option with a trial, but Sitvera's Apex feels like it better matches the coverage-for-price I was trying to land on without creeping into $449+.
Final rationalization
I initially picked Northpeak Atlas Pro Ergonomic Chair because it seemed like the best value under $400 and the trial period reduced risk; the Northpeak Atlas Min felt a bit too small for the money. After seeing the Sitvera Apex at $359, I can get a bigger-feeling panel for the same general spend target and keep this as a practical, not-huge-commitment purchase. I'm satisfied stopping here and buying the Apex.
Buyer session 12
Purchased Northpeak Atlas Elite Ergonomic Chair (sku_atlas_elite)
Final confidence: 0.74
Considered SKUs
Northpeak Atlas Pro Ergonomic Chair, Sitvera Apex Ergonomic Chair
Initial price impression
reasonable
Initial emotional reaction
I want good lumbar support without overspending. The mid-tier options look like the sweet spot.
Initial decision
Purchased
Initial selected SKU
Northpeak Atlas Elite Ergonomic Chair (sku_atlas_elite)
Initial confidence
0.72
Primary reason
Wanted adjustable lumbar and headrest; Atlas Elite fit my budget after comparing to Sitvera.
Secondary reasons
Build quality and warranty; good reviews for long sessions.
Price perception summary
Atlas Elite is at the top of my range but still feels justified for daily use.
Post-decision rationalization
I compared to Sitvera; the Northpeak had the features I cared about and I stayed with it.
Competitive research
Yes
Post-research reaction
Sitvera Apex was close on price but Northpeak Elite had better adjustability for my setup.
Decision changed
false
Final decision
Purchased
Final selected SKU
Northpeak Atlas Elite Ergonomic Chair (sku_atlas_elite)
Final confidence
0.74
Confidence delta
0.02
Research impact summary
Research confirmed my choice; no need to switch.
Final rationalization
Stuck with Northpeak Atlas Elite; it matched my needs and budget.
Buyer session 88
No purchase
Final confidence: 0.41
Considered SKUs
Sitvera Apex Ergonomic Chair, Northpeak Atlas Min Ergonomic Chair
Initial price impression
high
Initial emotional reaction
Prices are steeper than I expected; not sure I can justify it right now.
Initial decision
No purchase
Initial selected SKU
—
Initial confidence
0.38
Primary reason
Could not justify spend; will revisit when budget allows.
Secondary reasons
None; deferred purchase.
Price perception summary
Both options felt above my current comfort zone.
Post-decision rationalization
Decided to wait rather than stretch the budget.
Competitive research
Yes
Post-research reaction
Looked at a few alternatives; still nothing in range.
Decision changed
false
Final decision
No purchase
Final selected SKU
—
Final confidence
0.41
Confidence delta
0.03
Research impact summary
Research did not change outcome; still deferring.
Final rationalization
No purchase; will revisit later.

Test pricing decisions in minutes, not weeks — without revenue risk.

Loblo simulations deliver weeks of high-fidelity conversion data within minutes, so you can test hypothesis boldly and deploy quickly without waiting for months.

Simulation of Price Scenarios
Baseline
(0 out of 1000 buyer session simulations completed)
Moderate Discount
(0 out of 1000 buyer session simulations completed)
Aggressive Discount
(0 out of 1000 buyer session simulations completed)
Moderate price increase
(0 out of 1000 buyer session simulations completed)
Aggressive price increase
(0 out of 1000 buyer session simulations completed)
Simulation in progress

Powerful analytics and deep insights create effective strategies

Changing the price of one SKU secretly affects the rest of the portfolio. Our engine models how one SKU shifts demand, margin, and perception across the catalog, and turns it into actionable insights.

Portfolio Results Across Scenarios
5,000 buyer sessions across 5 scenarios (1,000 per scenario)
WINNING SCENARIO
Moderate price increase
(per 1,000 buyer sessions)
REVENUE$87,500 USD ▲ +4.9%
GROSS PROFIT$28,200 USD ▲ +5.1%
GROSS MARGIN32.2% ▲ +0.2pp
UNITS SOLD120 ▲ +5.3%
COMPETITOR LOSSES63 ▼ -14.9%
RUNNER-UP
Moderate Discount
(per 1,000 buyer sessions)
REVENUE$92,100 USD ▲ +5.8%
GROSS PROFIT$26,800 USD ▲ +4.6%
GROSS MARGIN29.1%
UNITS SOLD204 ▲ +78.9%
COMPETITOR LOSSES61 ▼ -17.6%

Portfolio Summary & Analysis

Revenue Composition

$100k $75k $50k $25k $0 Amount (USD) Revenue$83.4kBaseline Revenue$91.2kModerateDiscount Revenue$88.1kAggressiveDiscount Revenue$87.5kModerate priceincrease Revenue$85.0kAggressive priceincrease
Gross Profit Cost

Distribution of Units Sold

Baseline
Moderate Discount
Aggressive Discount
Moderate price increase
Aggressive price increase
Northpeak Atlas Pro Ergonomic Chair Northpeak Atlas Elite Ergonomic Chair Northpeak Atlas Min Ergonomic Chair Northpeak Atlas Pro Plus Northpeak Atlas Elite Plus

Understand competition from the lens of your customers

87% of buyers research before making a decision. Our simulations not only model buyers against different pricing scenarios internally, but also how they react to researching market alternatives and competitor discounts. Having access to full customer journeys beyond internal evaluations reveals exactly which SKUs are leaking to which competitors and why, so you can optimize with targeted pricing strategies instead of flat portfolio-wide promotions.

Research Impact By SKU

SKUSessions with researchLost to competitor (Post-research)Research dropoff %
Northpeak Atlas Pro Ergonomic Chair
sku_atlas_pro		15Total 7
Sitvera Apex Ergonomic Chair (7)		46.7%
Northpeak Atlas Elite Ergonomic Chair
sku_atlas_elite		9Total 7
Sitvera Apex (7)		77.8%
Northpeak Atlas Min Ergonomic Chair
sku_atlas_min		9Total 4
Sitvera Apex (4)		44.4%
Northpeak Atlas Pro Plus
sku_atlas_pro_plus		15Total 2
Sitvera Apex (1)
Sitvera Base (1)		13.3%
Northpeak Atlas Elite Plus
sku_atlas_elite_plus		10Total 2
Sitvera Apex (2)		20.0%

Join industry leaders redefining pricing strategy

We help growth teams across $10M DTC brands to $500M retail organizations move from reactive testing to proactive modelling to improve ROAS, revenue, margins and market share.

Request Access →